In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 4, 2000, Pages 521-524

  Del Mar Tavío, María ^a   Vila, Jordi ^b   Ruiz, Joaquím ^b   Amicosante, Gianfranco ^c   Franceschini, Nicola ^c   Martín Sánchez, Antonio M ^a   Jiménez De Anta, María Teresa ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM MUTANT; CITROBACTER FREUNDII; CONTROLLED STUDY; NONHUMAN;

EID: 0034114295     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.4.521     Document Type: Article

References (10)

1. Aoyama, H., Fujimaki, K., Sato, K., Fuji, T., Inoue, M., Hirai, K. et al. (1988). Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrobial Agents and Chemotherapy 32, 922-4.
2. Nishino, J., Deguchi, T., Yasuda, M., Kawamura, T., Nakano, M., Kanematsu, E. et al. (1997). Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii. FEMS Microbiology Letters 154, 409-14.
3. Weigel, L. M., Steward, C. D. & Tenover, F. C. (1998). gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 42, 2661-7.
4. Vila, J., Ruiz, J., Goñi, P. & Jiménez de Anta, M. T. (1996). Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy 40, 491-3.
5. Tavío, del Mar M., Vila, J., Ruiz, J., Ruiz, J., Martín-Sánchez, A. M. & Jiménez de Anta, M. T. (1999). Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. Journal of Antimicrobial Chemotherapy 44, 735-42.
6. Marshall, N. J. & Piddock, L. J. V. (1997). Antibacterial efflux systems. Microbiología 13, 285-300.
7. National Committee for Clinical Laboratory Standards. (1996). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
8. Sawai, T., Hiruma, R., Kawana, N., Kaneko, M., Taniyasu, F. & Inami, A. (1982). Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 22, 585-92.
9. Peterson, A. A. & McGroarty, E. J. (1985). High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. Journal of Bacteriology 162, 738-45.
10. Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. Journal of Bacteriology 154, 269-77.